Anti-angiogenesis: making the tumor vulnerable to the immune system.
about
Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?An update on vaccine therapy and other immunotherapeutic approaches for glioblastomaFunctional nanoparticles for magnetic resonance imaging.Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevanceCombining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer modelsThiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.The immunologic aspects of poxvirus oncolytic therapyImmunotherapy for neuro-oncology: the critical rationale for combinatorial therapy.Addition of an induction regimen of antiangiogenesis and antitumor immunity to standard chemotherapy improves survival in advanced malignanciesSimultaneous targeting of tumor antigens and the tumor vasculature using T lymphocyte transfer synergize to induce regression of established tumors in mice.Treatment with Tie2-siRNA in combination with carboplatin suppresses the growth of Ishikawa human endometrial carcinoma cell xenografts in vivo.Remodeling of tumor stroma and response to therapy.IL-32-dependent effects of IL-1beta on endothelial cell functionsThe roles of mast cells in anticancer immunity.The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.Preconditioning thermal therapy: flipping the switch on IL-6 for anti-tumour immunity.Vascular remodeling in cancer.Targeting angiogenesis in lung cancer - Pitfalls in drug development.Synergistic antitumor effect of combining metronomic chemotherapy with adoptive cell immunotherapy in nude mice.Immunogenicity and efficacy of a rationally designed vaccine against vascular endothelial growth factor in mouse solid tumor models.Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment.DNAzyme targeting c-jun suppresses skin cancer growth.Calreticulin promotes tumor lymphocyte infiltration and enhances the antitumor effects of immunotherapy by up-regulating the endothelial expression of adhesion molecules.Endostatin enhances antitumor effect of tumor antigen-pulsed dendritic cell therapy in mouse xenograft model of lung carcinoma.Reply to Marchiò et al.: Antitumor immune regulation by angiostatic therapy.Endothelial plasticity governs the site-specific leukocyte recruitment in hepatocellular cancer.Relationship between gingival angiopoietin-1 concentrations and depth of the adjacent gingival sulcus.Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients.Angiogenesis for tumor vascular normalization of Endostar on hepatoma 22 tumor-bearing mice is involved in the immune response.Therapeutic efficacy of combined vaccination against tumor pericyte-associated antigens DLK1 and DLK2 in mice.
P2860
Q26778150-4828CF08-39C5-42F1-8BE8-664B6A772F24Q27024830-6D21FC5E-5811-42E6-B761-CF4B59B95AD7Q31067306-2BFF1486-1860-4510-BBFB-ADD522CDCB37Q34461430-6177692A-616E-46F4-AF7B-A6BA0BCD5DB8Q34782683-EDC0FFF9-2C37-4AD4-87F6-D026890E2250Q35161285-9972A9EF-2063-45A1-B340-52BA50A2ED44Q36115128-D7A4E6CC-2784-477D-8C49-7B65D010EC0EQ36224057-598D22D7-0F53-4F2F-ADD7-472D2DBCB040Q36420816-A533CFC4-5FD2-4D8A-BD62-E43A62CF96BBQ36938866-9E865DB3-44BF-4E9F-8E9C-3F5CCCE68CD0Q36981008-55D9C885-B73F-4D61-AC33-D115C94DA418Q37016995-7E8571AC-6F34-4EA6-A684-5F83C13B5822Q37129422-77184724-9A83-4135-BC47-CBDD56E22B79Q37256987-BE334A5D-88B6-4705-B17D-FD90108D3124Q37516448-BF76EC28-C944-46D7-B270-4E4296C5916BQ38122205-4611ED64-D2E0-469A-A39A-2936B7039706Q38126351-0752379D-7766-4928-8F15-3162B43A94F7Q38389997-50B9BB05-DB7A-4DB8-929E-420238022475Q39015610-CD3D69C3-2EC5-49F1-889D-B8C868D14561Q39165919-F898157F-8D4C-4B4C-852D-DC19CC54BC04Q39220891-54FAC491-037C-4DF2-8C67-E354C627C042Q39326899-A2F5F886-AA4F-4DD8-96CF-FD34FDFA5848Q39497260-21657B9C-F228-4374-9CD7-7F38C5D5CF57Q41062063-87187D86-E66C-4367-A8B7-9267DE57D5A2Q42290718-1F84E04F-2D8D-4667-AEBA-882A928BDB6EQ43413284-CB1EAD05-D074-41B9-9D69-4EB97A8C4EB3Q45791189-330B5DB1-5416-4BA8-A458-1D6563721503Q47122277-E583D254-1E08-4B98-9070-7645AC13B5F2Q50204216-E4F5B771-5F0D-4ABF-855F-385747374E01Q52881532-9D6F589C-8A01-45DE-8784-CF638CA6322C
P2860
Anti-angiogenesis: making the tumor vulnerable to the immune system.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-angiogenesis: making the tumor vulnerable to the immune system.
@en
Anti-angiogenesis: making the tumor vulnerable to the immune system.
@nl
type
label
Anti-angiogenesis: making the tumor vulnerable to the immune system.
@en
Anti-angiogenesis: making the tumor vulnerable to the immune system.
@nl
prefLabel
Anti-angiogenesis: making the tumor vulnerable to the immune system.
@en
Anti-angiogenesis: making the tumor vulnerable to the immune system.
@nl
P2860
P1476
Anti-angiogenesis: making the tumor vulnerable to the immune system.
@en
P2093
Arjan W Griffioen
P2860
P2888
P304
P356
10.1007/S00262-008-0524-3
P577
2008-04-26T00:00:00Z
2008-10-01T00:00:00Z